chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Blood culture, Blood sodium decreased, C-reactive protein increased, COVID-19, COVID-19 pneumonia
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 2/10/21 (EN6201) Pfizer Dose 2 3/6/21 (EN6199) COVID Positive 9/23/21  9/28/21: Patient is an 89-year-old male with past medical history of BPH, hypertension, aortic valve replacement, and arthritis.  He presented to the emergency department on 09/20/2021 with chief complaint of fever and shortness of breath.  Patient has been vaccinated against COVID-19.  He received his 2 shots in February and March of this year. He recently attended a wedding on 09/18/2021.  He believes that he contracted COVID-19 at the event as he began experiencing symptoms 2 or 3 days after.  He was previously tested for COVID-19 and found to be positive.  The patient did receive monoclonal antibodies as an outpatient yesterday.  Following monoclonal antibody infusion, the patient began to feel worse.  He had worsening of shortness of breath and also developed a fever.  He denies any chest pain or symptoms otherwise. He denies alcohol use, tobacco use, or illicit drug use.  Family history is noncontributory.   In the emergency department, patient had a temperature as high as 102.4° F. He was tachypneic and had dyspnea in the ED.  He desatted to 89% on room air as well.  He was requiring BiPAP in order to breathe comfortably given his dyspnea.  However, he did feel that he could probably breathe okay without the BiPAP.  He elected to continue the machine for now as he felt more comfortable while on it. Chest x-ray was concerning for multifocal pneumonia.  Two sets of blood cultures were obtained.  The patient's labs revealed a sodium of 128, troponin of 0.02, hemoglobin of 11.6.  His CRP was 13.90.  He was COVID-19 positive as well.  He was admitted for further management of his COVID-19 pneumonia.  10/13/21: as noted patient required supplemental oxygen as an outpatient was fully vaccinated receive monoclonal antibodies during admission, Decadron, remdesivir, Actemra, Rocephin/azithromycin.  Along with supportive, periodic diuresis with Lasix and nebulizer treatments oxygen requirements gradually weaned down to max of OptiFlow down to 3 L prior to discharge.  Pulmonary assisted during course of admission and cleared patient for dispo to acute rehab.  Can consider anticoagulation once thrombocytopenia improves.  has had precipitous decline in platelet numbers. Lovenox held, hit panel was sent which was negative. Platelets still below 100,000 anticoagulation as noted above is being held possibly due to viral/infectious etiology.  Can consider reinitiate Ng as clinically appropriate at acute rehab.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Dyspnoea, Haemoglobin decreased, Laboratory test normal, Malaise
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 2/10/21 (EN6201) Pfizer Dose 2 3/6/21 (EN6199) COVID Positive 9/23/21  9/28/21: Patient is an 89-year-old male with past medical history of BPH, hypertension, aortic valve replacement, and arthritis.  He presented to the emergency department on 09/20/2021 with chief complaint of fever and shortness of breath.  Patient has been vaccinated against COVID-19.  He received his 2 shots in February and March of this year. He recently attended a wedding on 09/18/2021.  He believes that he contracted COVID-19 at the event as he began experiencing symptoms 2 or 3 days after.  He was previously tested for COVID-19 and found to be positive.  The patient did receive monoclonal antibodies as an outpatient yesterday.  Following monoclonal antibody infusion, the patient began to feel worse.  He had worsening of shortness of breath and also developed a fever.  He denies any chest pain or symptoms otherwise. He denies alcohol use, tobacco use, or illicit drug use.  Family history is noncontributory.   In the emergency department, patient had a temperature as high as 102.4° F. He was tachypneic and had dyspnea in the ED.  He desatted to 89% on room air as well.  He was requiring BiPAP in order to breathe comfortably given his dyspnea.  However, he did feel that he could probably breathe okay without the BiPAP.  He elected to continue the machine for now as he felt more comfortable while on it. Chest x-ray was concerning for multifocal pneumonia.  Two sets of blood cultures were obtained.  The patient's labs revealed a sodium of 128, troponin of 0.02, hemoglobin of 11.6.  His CRP was 13.90.  He was COVID-19 positive as well.  He was admitted for further management of his COVID-19 pneumonia.  10/13/21: as noted patient required supplemental oxygen as an outpatient was fully vaccinated receive monoclonal antibodies during admission, Decadron, remdesivir, Actemra, Rocephin/azithromycin.  Along with supportive, periodic diuresis with Lasix and nebulizer treatments oxygen requirements gradually weaned down to max of OptiFlow down to 3 L prior to discharge.  Pulmonary assisted during course of admission and cleared patient for dispo to acute rehab.  Can consider anticoagulation once thrombocytopenia improves.  has had precipitous decline in platelet numbers. Lovenox held, hit panel was sent which was negative. Platelets still below 100,000 anticoagulation as noted above is being held possibly due to viral/infectious etiology.  Can consider reinitiate Ng as clinically appropriate at acute rehab.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, Platelet count decreased, Polyuria, Positive airway pressure therapy, Pyrexia
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 2/10/21 (EN6201) Pfizer Dose 2 3/6/21 (EN6199) COVID Positive 9/23/21  9/28/21: Patient is an 89-year-old male with past medical history of BPH, hypertension, aortic valve replacement, and arthritis.  He presented to the emergency department on 09/20/2021 with chief complaint of fever and shortness of breath.  Patient has been vaccinated against COVID-19.  He received his 2 shots in February and March of this year. He recently attended a wedding on 09/18/2021.  He believes that he contracted COVID-19 at the event as he began experiencing symptoms 2 or 3 days after.  He was previously tested for COVID-19 and found to be positive.  The patient did receive monoclonal antibodies as an outpatient yesterday.  Following monoclonal antibody infusion, the patient began to feel worse.  He had worsening of shortness of breath and also developed a fever.  He denies any chest pain or symptoms otherwise. He denies alcohol use, tobacco use, or illicit drug use.  Family history is noncontributory.   In the emergency department, patient had a temperature as high as 102.4° F. He was tachypneic and had dyspnea in the ED.  He desatted to 89% on room air as well.  He was requiring BiPAP in order to breathe comfortably given his dyspnea.  However, he did feel that he could probably breathe okay without the BiPAP.  He elected to continue the machine for now as he felt more comfortable while on it. Chest x-ray was concerning for multifocal pneumonia.  Two sets of blood cultures were obtained.  The patient's labs revealed a sodium of 128, troponin of 0.02, hemoglobin of 11.6.  His CRP was 13.90.  He was COVID-19 positive as well.  He was admitted for further management of his COVID-19 pneumonia.  10/13/21: as noted patient required supplemental oxygen as an outpatient was fully vaccinated receive monoclonal antibodies during admission, Decadron, remdesivir, Actemra, Rocephin/azithromycin.  Along with supportive, periodic diuresis with Lasix and nebulizer treatments oxygen requirements gradually weaned down to max of OptiFlow down to 3 L prior to discharge.  Pulmonary assisted during course of admission and cleared patient for dispo to acute rehab.  Can consider anticoagulation once thrombocytopenia improves.  has had precipitous decline in platelet numbers. Lovenox held, hit panel was sent which was negative. Platelets still below 100,000 anticoagulation as noted above is being held possibly due to viral/infectious etiology.  Can consider reinitiate Ng as clinically appropriate at acute rehab.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Tachypnoea, Thrombocytopenia, Troponin normal, Vaccine breakthrough infection
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 2/10/21 (EN6201) Pfizer Dose 2 3/6/21 (EN6199) COVID Positive 9/23/21  9/28/21: Patient is an 89-year-old male with past medical history of BPH, hypertension, aortic valve replacement, and arthritis.  He presented to the emergency department on 09/20/2021 with chief complaint of fever and shortness of breath.  Patient has been vaccinated against COVID-19.  He received his 2 shots in February and March of this year. He recently attended a wedding on 09/18/2021.  He believes that he contracted COVID-19 at the event as he began experiencing symptoms 2 or 3 days after.  He was previously tested for COVID-19 and found to be positive.  The patient did receive monoclonal antibodies as an outpatient yesterday.  Following monoclonal antibody infusion, the patient began to feel worse.  He had worsening of shortness of breath and also developed a fever.  He denies any chest pain or symptoms otherwise. He denies alcohol use, tobacco use, or illicit drug use.  Family history is noncontributory.   In the emergency department, patient had a temperature as high as 102.4° F. He was tachypneic and had dyspnea in the ED.  He desatted to 89% on room air as well.  He was requiring BiPAP in order to breathe comfortably given his dyspnea.  However, he did feel that he could probably breathe okay without the BiPAP.  He elected to continue the machine for now as he felt more comfortable while on it. Chest x-ray was concerning for multifocal pneumonia.  Two sets of blood cultures were obtained.  The patient's labs revealed a sodium of 128, troponin of 0.02, hemoglobin of 11.6.  His CRP was 13.90.  He was COVID-19 positive as well.  He was admitted for further management of his COVID-19 pneumonia.  10/13/21: as noted patient required supplemental oxygen as an outpatient was fully vaccinated receive monoclonal antibodies during admission, Decadron, remdesivir, Actemra, Rocephin/azithromycin.  Along with supportive, periodic diuresis with Lasix and nebulizer treatments oxygen requirements gradually weaned down to max of OptiFlow down to 3 L prior to discharge.  Pulmonary assisted during course of admission and cleared patient for dispo to acute rehab.  Can consider anticoagulation once thrombocytopenia improves.  has had precipitous decline in platelet numbers. Lovenox held, hit panel was sent which was negative. Platelets still below 100,000 anticoagulation as noted above is being held possibly due to viral/infectious etiology.  Can consider reinitiate Ng as clinically appropriate at acute rehab.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy, Postmenopausal haemorrhage, Rash
Clinical narrative: I received the vaccine the next morning a rash had appeared on the left arm and  two days later it spread to my right arm. I went to the Dermatologists and they gave me  sluocinonide for that rash, and it went away in a bout a week. Then a few months later I had a post menopausal cycle. I went to the gynecologists and they did a uterine biopsy and it came back negative, they said that I will need to watch it and if I start to bleed again i will need to see them immediately.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Asthenia, Headache, Pain, Pyrexia
Clinical narrative: Patient had fever to 100 evening of dose which lasted 24 hours.  Since night of the vaccine had severe HA which prevented her from going to school.  Also reported abdominal pain and body aches, low energy.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Suspected COVID-19, Vaccine breakthrough infection
Clinical narrative: Suspect COVID breakthrough case
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Poor quality product administered
Clinical narrative: Patient does not call or refers any adverse problem. No viable vaccine.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Abstains from recreational drugs, Angiogram pulmonary abnormal, Blood albumin decreased, Blood alkaline phosphatase increased, Blood bilirubin increased
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 3/1/21 (EN6200) Pfizer Dose 2 3/24/21 (ER2613) COVID Positive 9/29/21  10/7/21: Patient is a 79-year-old male who presents to the emergency department today with complaints of worsening shortness of breath.  Patient's accompanying symptoms include persistent cough, fatigue, decreased appetite, fevers, body aches.  Patient states the symptoms started about 2 weeks ago.  He tested positive for COVID-19 on 09/29/2021, received outpatient COVID-19 antibody infusion on 10/01/2021.  The patient states his symptoms have progressively gotten worse and today he felt as if he could not catch his breath which subsequently led his arrival to the emergency department.  The patient is vaccinated for COVID-19.  Patient has a past medical history significant for type 2 diabetes, hypothyroidism, anxiety, hypertension, hyperlipidemia.   Upon arrival to ED patient's temperature is 100.5°, heart rate 106, respirations 24, pulse ox 88% on room air, blood pressure 133/67.  Patient was placed on 4 L oxygen via nasal cannula to maintain O2 saturations greater than 90%. Patient received DuoNeb x1, Decadron 6 mg x1, 750 mg IV Levaquin x1, 1 L IV normal saline in ED.  chest x-ray reveals patchy bilateral airspace disease, concerning for multifocal pneumonia.  CT angio chest is negative for PE, scattered bilateral areas of airspace disease likely representing viral pneumonitis or multilobar pneumonia. Patient's laboratory findings are significant for hemoglobin 11.8, hematocrit 36.2, D-dimer 1.33, CRP 19.40, sodium 133, glucose 341, ALP 172, bili 1.3, albumin 3.1.   Patient was seen and examined at the bedside in the ED, patient is in mild respiratory distress.  The patient continues to complain of shortness of breath, fatigue, generalized illness.  Patient denies any alcohol abuse, tobacco use or illicit drug abuse.  10/12/21: 79-year-old man who presented worsening shortness of breath despite outpatient monoclonal antibody infusion following recent diagnosis of COVID-19 infection.  He presented to the emergency department where he was noted to be hypoxic, chest x-ray and CT pulmonary angiogram confirmed bilateral airspace disease without pulmonary embolism.  He was admitted to the hospitalist Service, treated with Actemra, IV steroids, empiric antibiotic therapy as well as antiviral therapy remdesivir.  Clinical response was favorable with progressive improvement in oxygen requirements, shortness of breath and other respiratory symptoms.  Oxygen walk for home determination prior to discharge was done, he was noted to require 3 liters/minute with activity and no supplemental oxygen at rest.  He was discharged in stable medical condition to continue outpatient follow-up.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose increased, Blood sodium decreased, C-reactive protein increased, COVID-19, Chest X-ray abnormal
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 3/1/21 (EN6200) Pfizer Dose 2 3/24/21 (ER2613) COVID Positive 9/29/21  10/7/21: Patient is a 79-year-old male who presents to the emergency department today with complaints of worsening shortness of breath.  Patient's accompanying symptoms include persistent cough, fatigue, decreased appetite, fevers, body aches.  Patient states the symptoms started about 2 weeks ago.  He tested positive for COVID-19 on 09/29/2021, received outpatient COVID-19 antibody infusion on 10/01/2021.  The patient states his symptoms have progressively gotten worse and today he felt as if he could not catch his breath which subsequently led his arrival to the emergency department.  The patient is vaccinated for COVID-19.  Patient has a past medical history significant for type 2 diabetes, hypothyroidism, anxiety, hypertension, hyperlipidemia.   Upon arrival to ED patient's temperature is 100.5°, heart rate 106, respirations 24, pulse ox 88% on room air, blood pressure 133/67.  Patient was placed on 4 L oxygen via nasal cannula to maintain O2 saturations greater than 90%. Patient received DuoNeb x1, Decadron 6 mg x1, 750 mg IV Levaquin x1, 1 L IV normal saline in ED.  chest x-ray reveals patchy bilateral airspace disease, concerning for multifocal pneumonia.  CT angio chest is negative for PE, scattered bilateral areas of airspace disease likely representing viral pneumonitis or multilobar pneumonia. Patient's laboratory findings are significant for hemoglobin 11.8, hematocrit 36.2, D-dimer 1.33, CRP 19.40, sodium 133, glucose 341, ALP 172, bili 1.3, albumin 3.1.   Patient was seen and examined at the bedside in the ED, patient is in mild respiratory distress.  The patient continues to complain of shortness of breath, fatigue, generalized illness.  Patient denies any alcohol abuse, tobacco use or illicit drug abuse.  10/12/21: 79-year-old man who presented worsening shortness of breath despite outpatient monoclonal antibody infusion following recent diagnosis of COVID-19 infection.  He presented to the emergency department where he was noted to be hypoxic, chest x-ray and CT pulmonary angiogram confirmed bilateral airspace disease without pulmonary embolism.  He was admitted to the hospitalist Service, treated with Actemra, IV steroids, empiric antibiotic therapy as well as antiviral therapy remdesivir.  Clinical response was favorable with progressive improvement in oxygen requirements, shortness of breath and other respiratory symptoms.  Oxygen walk for home determination prior to discharge was done, he was noted to require 3 liters/minute with activity and no supplemental oxygen at rest.  He was discharged in stable medical condition to continue outpatient follow-up.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Decreased appetite, Dyspnoea, Fatigue, Fibrin D dimer
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 3/1/21 (EN6200) Pfizer Dose 2 3/24/21 (ER2613) COVID Positive 9/29/21  10/7/21: Patient is a 79-year-old male who presents to the emergency department today with complaints of worsening shortness of breath.  Patient's accompanying symptoms include persistent cough, fatigue, decreased appetite, fevers, body aches.  Patient states the symptoms started about 2 weeks ago.  He tested positive for COVID-19 on 09/29/2021, received outpatient COVID-19 antibody infusion on 10/01/2021.  The patient states his symptoms have progressively gotten worse and today he felt as if he could not catch his breath which subsequently led his arrival to the emergency department.  The patient is vaccinated for COVID-19.  Patient has a past medical history significant for type 2 diabetes, hypothyroidism, anxiety, hypertension, hyperlipidemia.   Upon arrival to ED patient's temperature is 100.5°, heart rate 106, respirations 24, pulse ox 88% on room air, blood pressure 133/67.  Patient was placed on 4 L oxygen via nasal cannula to maintain O2 saturations greater than 90%. Patient received DuoNeb x1, Decadron 6 mg x1, 750 mg IV Levaquin x1, 1 L IV normal saline in ED.  chest x-ray reveals patchy bilateral airspace disease, concerning for multifocal pneumonia.  CT angio chest is negative for PE, scattered bilateral areas of airspace disease likely representing viral pneumonitis or multilobar pneumonia. Patient's laboratory findings are significant for hemoglobin 11.8, hematocrit 36.2, D-dimer 1.33, CRP 19.40, sodium 133, glucose 341, ALP 172, bili 1.3, albumin 3.1.   Patient was seen and examined at the bedside in the ED, patient is in mild respiratory distress.  The patient continues to complain of shortness of breath, fatigue, generalized illness.  Patient denies any alcohol abuse, tobacco use or illicit drug abuse.  10/12/21: 79-year-old man who presented worsening shortness of breath despite outpatient monoclonal antibody infusion following recent diagnosis of COVID-19 infection.  He presented to the emergency department where he was noted to be hypoxic, chest x-ray and CT pulmonary angiogram confirmed bilateral airspace disease without pulmonary embolism.  He was admitted to the hospitalist Service, treated with Actemra, IV steroids, empiric antibiotic therapy as well as antiviral therapy remdesivir.  Clinical response was favorable with progressive improvement in oxygen requirements, shortness of breath and other respiratory symptoms.  Oxygen walk for home determination prior to discharge was done, he was noted to require 3 liters/minute with activity and no supplemental oxygen at rest.  He was discharged in stable medical condition to continue outpatient follow-up.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Haematocrit decreased, Haemoglobin decreased, Hypoxia, Illness, Lung disorder
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 3/1/21 (EN6200) Pfizer Dose 2 3/24/21 (ER2613) COVID Positive 9/29/21  10/7/21: Patient is a 79-year-old male who presents to the emergency department today with complaints of worsening shortness of breath.  Patient's accompanying symptoms include persistent cough, fatigue, decreased appetite, fevers, body aches.  Patient states the symptoms started about 2 weeks ago.  He tested positive for COVID-19 on 09/29/2021, received outpatient COVID-19 antibody infusion on 10/01/2021.  The patient states his symptoms have progressively gotten worse and today he felt as if he could not catch his breath which subsequently led his arrival to the emergency department.  The patient is vaccinated for COVID-19.  Patient has a past medical history significant for type 2 diabetes, hypothyroidism, anxiety, hypertension, hyperlipidemia.   Upon arrival to ED patient's temperature is 100.5°, heart rate 106, respirations 24, pulse ox 88% on room air, blood pressure 133/67.  Patient was placed on 4 L oxygen via nasal cannula to maintain O2 saturations greater than 90%. Patient received DuoNeb x1, Decadron 6 mg x1, 750 mg IV Levaquin x1, 1 L IV normal saline in ED.  chest x-ray reveals patchy bilateral airspace disease, concerning for multifocal pneumonia.  CT angio chest is negative for PE, scattered bilateral areas of airspace disease likely representing viral pneumonitis or multilobar pneumonia. Patient's laboratory findings are significant for hemoglobin 11.8, hematocrit 36.2, D-dimer 1.33, CRP 19.40, sodium 133, glucose 341, ALP 172, bili 1.3, albumin 3.1.   Patient was seen and examined at the bedside in the ED, patient is in mild respiratory distress.  The patient continues to complain of shortness of breath, fatigue, generalized illness.  Patient denies any alcohol abuse, tobacco use or illicit drug abuse.  10/12/21: 79-year-old man who presented worsening shortness of breath despite outpatient monoclonal antibody infusion following recent diagnosis of COVID-19 infection.  He presented to the emergency department where he was noted to be hypoxic, chest x-ray and CT pulmonary angiogram confirmed bilateral airspace disease without pulmonary embolism.  He was admitted to the hospitalist Service, treated with Actemra, IV steroids, empiric antibiotic therapy as well as antiviral therapy remdesivir.  Clinical response was favorable with progressive improvement in oxygen requirements, shortness of breath and other respiratory symptoms.  Oxygen walk for home determination prior to discharge was done, he was noted to require 3 liters/minute with activity and no supplemental oxygen at rest.  He was discharged in stable medical condition to continue outpatient follow-up.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Non-tobacco user, Pain, Pneumonia, Pneumonia viral, Pyrexia
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 3/1/21 (EN6200) Pfizer Dose 2 3/24/21 (ER2613) COVID Positive 9/29/21  10/7/21: Patient is a 79-year-old male who presents to the emergency department today with complaints of worsening shortness of breath.  Patient's accompanying symptoms include persistent cough, fatigue, decreased appetite, fevers, body aches.  Patient states the symptoms started about 2 weeks ago.  He tested positive for COVID-19 on 09/29/2021, received outpatient COVID-19 antibody infusion on 10/01/2021.  The patient states his symptoms have progressively gotten worse and today he felt as if he could not catch his breath which subsequently led his arrival to the emergency department.  The patient is vaccinated for COVID-19.  Patient has a past medical history significant for type 2 diabetes, hypothyroidism, anxiety, hypertension, hyperlipidemia.   Upon arrival to ED patient's temperature is 100.5°, heart rate 106, respirations 24, pulse ox 88% on room air, blood pressure 133/67.  Patient was placed on 4 L oxygen via nasal cannula to maintain O2 saturations greater than 90%. Patient received DuoNeb x1, Decadron 6 mg x1, 750 mg IV Levaquin x1, 1 L IV normal saline in ED.  chest x-ray reveals patchy bilateral airspace disease, concerning for multifocal pneumonia.  CT angio chest is negative for PE, scattered bilateral areas of airspace disease likely representing viral pneumonitis or multilobar pneumonia. Patient's laboratory findings are significant for hemoglobin 11.8, hematocrit 36.2, D-dimer 1.33, CRP 19.40, sodium 133, glucose 341, ALP 172, bili 1.3, albumin 3.1.   Patient was seen and examined at the bedside in the ED, patient is in mild respiratory distress.  The patient continues to complain of shortness of breath, fatigue, generalized illness.  Patient denies any alcohol abuse, tobacco use or illicit drug abuse.  10/12/21: 79-year-old man who presented worsening shortness of breath despite outpatient monoclonal antibody infusion following recent diagnosis of COVID-19 infection.  He presented to the emergency department where he was noted to be hypoxic, chest x-ray and CT pulmonary angiogram confirmed bilateral airspace disease without pulmonary embolism.  He was admitted to the hospitalist Service, treated with Actemra, IV steroids, empiric antibiotic therapy as well as antiviral therapy remdesivir.  Clinical response was favorable with progressive improvement in oxygen requirements, shortness of breath and other respiratory symptoms.  Oxygen walk for home determination prior to discharge was done, he was noted to require 3 liters/minute with activity and no supplemental oxygen at rest.  He was discharged in stable medical condition to continue outpatient follow-up.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory distress, Respiratory symptom, SARS-CoV-2 test positive, Vaccine breakthrough infection, Walking distance test
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 3/1/21 (EN6200) Pfizer Dose 2 3/24/21 (ER2613) COVID Positive 9/29/21  10/7/21: Patient is a 79-year-old male who presents to the emergency department today with complaints of worsening shortness of breath.  Patient's accompanying symptoms include persistent cough, fatigue, decreased appetite, fevers, body aches.  Patient states the symptoms started about 2 weeks ago.  He tested positive for COVID-19 on 09/29/2021, received outpatient COVID-19 antibody infusion on 10/01/2021.  The patient states his symptoms have progressively gotten worse and today he felt as if he could not catch his breath which subsequently led his arrival to the emergency department.  The patient is vaccinated for COVID-19.  Patient has a past medical history significant for type 2 diabetes, hypothyroidism, anxiety, hypertension, hyperlipidemia.   Upon arrival to ED patient's temperature is 100.5°, heart rate 106, respirations 24, pulse ox 88% on room air, blood pressure 133/67.  Patient was placed on 4 L oxygen via nasal cannula to maintain O2 saturations greater than 90%. Patient received DuoNeb x1, Decadron 6 mg x1, 750 mg IV Levaquin x1, 1 L IV normal saline in ED.  chest x-ray reveals patchy bilateral airspace disease, concerning for multifocal pneumonia.  CT angio chest is negative for PE, scattered bilateral areas of airspace disease likely representing viral pneumonitis or multilobar pneumonia. Patient's laboratory findings are significant for hemoglobin 11.8, hematocrit 36.2, D-dimer 1.33, CRP 19.40, sodium 133, glucose 341, ALP 172, bili 1.3, albumin 3.1.   Patient was seen and examined at the bedside in the ED, patient is in mild respiratory distress.  The patient continues to complain of shortness of breath, fatigue, generalized illness.  Patient denies any alcohol abuse, tobacco use or illicit drug abuse.  10/12/21: 79-year-old man who presented worsening shortness of breath despite outpatient monoclonal antibody infusion following recent diagnosis of COVID-19 infection.  He presented to the emergency department where he was noted to be hypoxic, chest x-ray and CT pulmonary angiogram confirmed bilateral airspace disease without pulmonary embolism.  He was admitted to the hospitalist Service, treated with Actemra, IV steroids, empiric antibiotic therapy as well as antiviral therapy remdesivir.  Clinical response was favorable with progressive improvement in oxygen requirements, shortness of breath and other respiratory symptoms.  Oxygen walk for home determination prior to discharge was done, he was noted to require 3 liters/minute with activity and no supplemental oxygen at rest.  He was discharged in stable medical condition to continue outpatient follow-up.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Fully vaccinated with two doses of Moderna. Tested positive for COVID 19 on 01/23/2022. Admitted to hospital on 01/23/2022. Expired on 02/10/2022 while still hospitalized.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient is only 16 and should not have received Moderna. Patient did not have any reaction.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Dyspnoea, Erythema, Lymphadenopathy
Clinical narrative: DAY AFTER 2ND SHOT RED ARM, SWOLLEN LYMPH IN NECK AND ARM BP AND SOB STARTED WITHIN 1 WEEK.  CONTINUED STILL.  BP IS NOT CONTROLLED  AND CONTINUE WITH SOB
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Cardiac stress test, Chest X-ray, Dyspnoea, Echocardiogram
Clinical narrative: SVT, A-Fib, hospitalized due to shortness of breath, perfuse sweating, excessive pulse rate
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram, Heart rate increased, Hyperhidrosis, Laboratory test, Supraventricular tachycardia
Clinical narrative: SVT, A-Fib, hospitalized due to shortness of breath, perfuse sweating, excessive pulse rate
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: No adverse event, Poor quality product administered
Clinical narrative: Patient does not call or refers any adverse problem. No viable vaccine.
Age: 0.58
Sex: F
Vaccine: PNC13
Symptoms: Mobility decreased, Weight bearing difficulty
Clinical narrative: pt was previously baring weight and rolling over and since the vaccine has stopped doing both
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products, No adverse event
Clinical narrative: Patient states he requested to receive Moderna booster upon arrival  to clinic but was directed to Pfizer table.  1st vaccine was J&J on 3/25/2021, Pfizer 0.3ml booster to patient.  Patient states he had normal side effects related to vaccine. Denies any adverse reaction.  Patient did not know he received Pfizer until he down loaded docket.  He assumed it was a docket error. States he contacted docket who informed him to contact the DOH.  Notified patient that he received Pfizer and not Moderna. Patient expressed understanding.  I will send new card with proper vaccine information.
Age: 2.0
Sex: F
Vaccine: HEPA
Symptoms: No adverse event
Clinical narrative: none
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, Blood test, Dyspnoea, Oedema, Oedema peripheral
Clinical narrative: I started having shortness of breath while walking. It has been gradually been increasing. I started getting edema in my stomach, legs, and feet.  I went to the doctor and they don't have a diagnosis yet, but they said that I am anemic. I was prescribed Lasix and an Advair inhaler, but it has not really helped yet.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: X-ray
Clinical narrative: I started having shortness of breath while walking. It has been gradually been increasing. I started getting edema in my stomach, legs, and feet.  I went to the doctor and they don't have a diagnosis yet, but they said that I am anemic. I was prescribed Lasix and an Advair inhaler, but it has not really helped yet.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Fully vaccinated with Three doses of Pfizer. Tested positive for COVID 19 on02/04/2022. Admitted to hospital on 02/04/2022. Expired on 02/08/2022 while still hospitalized.
Age: 20.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID positive in the ED most likely from prior infection on 01/12/2022
Age: 20.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Infection, SARS-CoV-2 test positive
Clinical narrative: COVID positive in the ED most likely from prior infection on 01/12/2022
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse affect reported from patient. Clinic held Moderna vaccine at lower temp than recommended by Modera. Vaccine was held at -90 to -60 degrees Celsius. Moderna deemed vaccine viable for use.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Poor quality product administered
Clinical narrative: Patient does not call or refers any adverse problem. No viable vaccine.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Lymph node pain, Lymphadenopathy, Pruritus, Rash
Clinical narrative: Received Covid 19 vaccine 1/26/22 and noticed swollen, tender itching area on my head along wit swollen and tender lymph nodes.  Was seen in urgent care 2/1/22 and given Doxycycline which I completed.  Rash continued to get worse and spread to different areas on my scalp.  Was seen at my Dermatologist office on 2/11/22 who positively diagnosed rash as Shingles.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Tenderness
Clinical narrative: Received Covid 19 vaccine 1/26/22 and noticed swollen, tender itching area on my head along wit swollen and tender lymph nodes.  Was seen in urgent care 2/1/22 and given Doxycycline which I completed.  Rash continued to get worse and spread to different areas on my scalp.  Was seen at my Dermatologist office on 2/11/22 who positively diagnosed rash as Shingles.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Pain in extremity
Clinical narrative: Painful right arm, and did not feel good with headache. Did not see doctor.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Urticaria
Clinical narrative: COVID-19 PCR is positive on February 14 she has no respiratory symptoms will discuss with Infectious Disease team regarding if urticaria is possible related to COVID 19.  In review her previous COVID test on February 1st at local emergency department was negative.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: C-reactive protein increased, Chest discomfort, Chest pain, Electrocardiogram ambulatory, Electrocardiogram normal
Clinical narrative: Elevated heart rate between 43-144 for intermittent times of day after exercise. This is accompanied by heart palpitations and chest pains. Noticeable discomfort in chest. No shortness of breath. Elevated heart rates may last for 1 min to up to 20min off and on for the afternoon/evening and following days. At first they would subside after a 1-2 days after exercise, now they are more frequent and only with very minor exercise or none at all. I am used to exercising a lot - doing martial arts, but now I cannot go outside and walk my dog without elevated heart rate in the 100's and drops down to 40's.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer, Heart rate decreased, Heart rate increased, Loss of personal independence in daily activities, Palpitations
Clinical narrative: Elevated heart rate between 43-144 for intermittent times of day after exercise. This is accompanied by heart palpitations and chest pains. Noticeable discomfort in chest. No shortness of breath. Elevated heart rates may last for 1 min to up to 20min off and on for the afternoon/evening and following days. At first they would subside after a 1-2 days after exercise, now they are more frequent and only with very minor exercise or none at all. I am used to exercising a lot - doing martial arts, but now I cannot go outside and walk my dog without elevated heart rate in the 100's and drops down to 40's.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate normal, SARS-CoV-2 antibody test, SARS-CoV-2 test negative, Troponin I increased
Clinical narrative: Elevated heart rate between 43-144 for intermittent times of day after exercise. This is accompanied by heart palpitations and chest pains. Noticeable discomfort in chest. No shortness of breath. Elevated heart rates may last for 1 min to up to 20min off and on for the afternoon/evening and following days. At first they would subside after a 1-2 days after exercise, now they are more frequent and only with very minor exercise or none at all. I am used to exercising a lot - doing martial arts, but now I cannot go outside and walk my dog without elevated heart rate in the 100's and drops down to 40's.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Echocardiogram, Electrocardiogram, Myocarditis
Clinical narrative: Myocarditis per cardiologist
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse affect reported from patient. Clinic held Moderna vaccine at lower temp than recommended by Modera. Vaccine was held at -90 to -60 degrees Celsius. Moderna deemed vaccine viable for use.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient is a 82-year-old female with COVID-19 infection (positive PCR on 2/2/2022),
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine moved from ultracold 12/01/21 to fridge to be used by 12/31/21 actual expiration 03/24/22, given to patient 01/05/2022 which was 5 days beyond use for refrigerator storage. Manufacturer notified and stated dose was still effective, repeat not necessary, patients notified.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Aphasia, Blood test, Breath holding, Chest discomfort, Condition aggravated
Clinical narrative: The patient has asthma. Thursday September 9 she thought she was having an asthma attack because she couldn't breathe and her chest was tight. She had no response to the rescue inhaler and she was taken to the hospital via ambulance to get steroids and was sent home. 24 hours later she fell to the floor and grabbed her chest and said she was having a heart attack. Her jaw was locked open and she couldn't speak. She was taken to the hospital via ambulance. Admitted to the hospital via ER. She was severely tachycardic and above 170. After 24 hours of having heart/breathing attacks in the hospital, she was transported to another hospital via ambulance due to her congenital heart defect. Upon arriving her attackes continued every 27-30 minutes. Her symptoms then attacked her limbs. Her right leg shot up in the air in a 90 degree angle and convulsed uncontrollably for 40 minutes. That happened for 24 hours. Her foot and hands would lock up in spasms. Throughout these five days in the hospital, she would become unconscience from 2 to 60 minutes.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Electrocardiogram, Fall, Heart disease congenital, Loss of consciousness
Clinical narrative: The patient has asthma. Thursday September 9 she thought she was having an asthma attack because she couldn't breathe and her chest was tight. She had no response to the rescue inhaler and she was taken to the hospital via ambulance to get steroids and was sent home. 24 hours later she fell to the floor and grabbed her chest and said she was having a heart attack. Her jaw was locked open and she couldn't speak. She was taken to the hospital via ambulance. Admitted to the hospital via ER. She was severely tachycardic and above 170. After 24 hours of having heart/breathing attacks in the hospital, she was transported to another hospital via ambulance due to her congenital heart defect. Upon arriving her attackes continued every 27-30 minutes. Her symptoms then attacked her limbs. Her right leg shot up in the air in a 90 degree angle and convulsed uncontrollably for 40 minutes. That happened for 24 hours. Her foot and hands would lock up in spasms. Throughout these five days in the hospital, she would become unconscience from 2 to 60 minutes.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging head, Muscle spasms, Myocardial infarction, Seizure, Tachycardia
Clinical narrative: The patient has asthma. Thursday September 9 she thought she was having an asthma attack because she couldn't breathe and her chest was tight. She had no response to the rescue inhaler and she was taken to the hospital via ambulance to get steroids and was sent home. 24 hours later she fell to the floor and grabbed her chest and said she was having a heart attack. Her jaw was locked open and she couldn't speak. She was taken to the hospital via ambulance. Admitted to the hospital via ER. She was severely tachycardic and above 170. After 24 hours of having heart/breathing attacks in the hospital, she was transported to another hospital via ambulance due to her congenital heart defect. Upon arriving her attackes continued every 27-30 minutes. Her symptoms then attacked her limbs. Her right leg shot up in the air in a 90 degree angle and convulsed uncontrollably for 40 minutes. That happened for 24 hours. Her foot and hands would lock up in spasms. Throughout these five days in the hospital, she would become unconscience from 2 to 60 minutes.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Trismus
Clinical narrative: The patient has asthma. Thursday September 9 she thought she was having an asthma attack because she couldn't breathe and her chest was tight. She had no response to the rescue inhaler and she was taken to the hospital via ambulance to get steroids and was sent home. 24 hours later she fell to the floor and grabbed her chest and said she was having a heart attack. Her jaw was locked open and she couldn't speak. She was taken to the hospital via ambulance. Admitted to the hospital via ER. She was severely tachycardic and above 170. After 24 hours of having heart/breathing attacks in the hospital, she was transported to another hospital via ambulance due to her congenital heart defect. Upon arriving her attackes continued every 27-30 minutes. Her symptoms then attacked her limbs. Her right leg shot up in the air in a 90 degree angle and convulsed uncontrollably for 40 minutes. That happened for 24 hours. Her foot and hands would lock up in spasms. Throughout these five days in the hospital, she would become unconscience from 2 to 60 minutes.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient was administered vaccine beyond the published expiration date. Per Moderna Manufacterer, re-vaccination is not required, the vaccine was determined to still maintain the activity necessary to protect against Covid-19.
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Event occurred after 3d vaccine; breakthrough case admission
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Erythema, Peripheral swelling, Rash pruritic, Skin weeping
Clinical narrative: Yellowish fluid oozing from arm, swelling in arm, itchy rash on stomach, redness above elbow, itchiness became mild.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Fatigue, SARS-CoV-2 test positive
Clinical narrative: Worsening shortness of breath and fatigue in the setting of diagnosed COVID-19 infection via home test 02/07/2022.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient was administered vaccine beyond the published expiration date. Per Moderna Manufacterer, re-vaccination is not required, the vaccine was determined to still maintain the activity necessary to protect against Covid-19.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Blood test, C-reactive protein increased, Chapped lips
Clinical narrative: 2 weeks after second dose patient was freezing, tired, weak, racing heart, nauseated, dizzy, achy joints.  3 weeks after second dose, patient had swelling of hands and feet and had a severe full body rash that lasted about 10 days. She said her lips felt like cracked leather.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Feeling cold, Nausea, Palpitations
Clinical narrative: 2 weeks after second dose patient was freezing, tired, weak, racing heart, nauseated, dizzy, achy joints.  3 weeks after second dose, patient had swelling of hands and feet and had a severe full body rash that lasted about 10 days. She said her lips felt like cracked leather.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Peripheral swelling, Rash
Clinical narrative: 2 weeks after second dose patient was freezing, tired, weak, racing heart, nauseated, dizzy, achy joints.  3 weeks after second dose, patient had swelling of hands and feet and had a severe full body rash that lasted about 10 days. She said her lips felt like cracked leather.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Fully vaccinated with 3 doses of Pfizer. Tested positive for COVID 19 on 01/24/2022. Admitted to Hospital on 01/08/2022. Expired on 02/08/2022 while still hospitalized.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: He had a positive SARs CoV-2 PCR on 1/6/22. Patient called to ask about his recent positive COVID test. He states he still has shortness of breath and it may be getting worse over the last two days
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse affect reported from patient. Clinic held Moderna vaccine at lower temp than recommended by Modera. Vaccine was held at -90 to -60 degrees Celsius. Moderna deemed vaccine viable for use.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient was administered vaccine beyond the published expiration date. Per Moderna Manufacterer, re-vaccination is not required, the vaccine was determined to still maintain the activity necessary to protect against Covid-19.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cough, Headache, Pain, Pyrexia, Vaccine positive rechallenge
Clinical narrative: I got my booster shot of Moderna Covid-19 vaccine on Jan 4, 2022 and started coughing after a few hours of getting it. And I am still coughing until today 2/15/2022, it has been six weeks. I also got other side effects such as headache and fever, body ache, but they all disappeared after 48-72 hours, but my cough still exists. I got the same side effects after I got second shot last year 2/22/2021.  I?m going to see pulmonologist due to this side effect to get a thorough exam.  Moderna  should pay all the cost.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Event occurred after second vaccine; breakthrough case hospitalization
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray, Electrocardiogram, Electrocardiogram ambulatory, Hypertension, Laboratory test
Clinical narrative: Began having episodes of racing heart in October 2021. Multiple times per day, unexplained. On 11/18/2021 had an episode of sustained tachycardia (heart rate up to 180's) and HTN (180/120). Presented to emergency department for this episode. No etiology identified. Continue to have multiple episodes of tachycardia throughout the day.  Cardiology appointment pending.